Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus

Striepe K, Jumar A, Ott C, Karg M, Schneider M, Kannenkeril D, Schmieder R (2017)

Publication Type: Journal article

Publication year: 2017

Journal

Circulation American Heart Association

Book Volume: 136

Pages Range: 1167-1169

Journal Issue: 12

DOI: 10.1161/CIRCULATIONAHA.117.029529

Authors with CRIS profile

Kristina Striepe Professur für Innere Medizin (Nephrologie) Christian Ott Medizinische Fakultät Margarete Karg Department of Medicine 5 – Haematology and Oncology Markus Schneider Medizinische Fakultät Roland Schmieder Professur für Innere Medizin (Nephrologie)

How to cite

APA:

Striepe, K., Jumar, A., Ott, C., Karg, M., Schneider, M., Kannenkeril, D., & Schmieder, R. (2017). Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus. Circulation, 136(12), 1167-1169. https://dx.doi.org/10.1161/CIRCULATIONAHA.117.029529

MLA:

Striepe, Kristina, et al. "Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus." Circulation 136.12 (2017): 1167-1169.

BibTeX: Download